Literature DB >> 26456803

Indications and Types of Antibiotic Agents Used in 6 Acute Care Hospitals, 2009-2010: A Pragmatic Retrospective Observational Study.

Theodoros Kelesidis1, Nikolay Braykov2, Daniel Z Uslan1, Daniel J Morgan2, Sumanth Gandra2, Birgir Johannsson3, Marin L Schweizer3, Scott A Weisenberg4, Heather Young5, Joseph Cantey6, Eli Perencevich3, Edward Septimus7, Arjun Srinivasan8, Ramanan Laxminarayan2.   

Abstract

BACKGROUND To design better antimicrobial stewardship programs, detailed data on the primary drivers and patterns of antibiotic use are needed. OBJECTIVE To characterize the indications for antibiotic therapy, agents used, duration, combinations, and microbiological justification in 6 acute-care US facilities with varied location, size, and type of antimicrobial stewardship programs. DESIGN, PARTICIPANTS, AND SETTING Retrospective medical chart review was performed on a random cross-sectional sample of 1,200 adult inpatients, hospitalized (>24 hrs) in 6 hospitals, and receiving at least 1 antibiotic dose on 4 index dates chosen at equal intervals through a 1-year study period (October 1, 2009-September 30, 2010). METHODS Infectious disease specialists recorded patient demographic characteristics, comorbidities, microbiological and radiological testing, and agents used, dose, duration, and indication for antibiotic prescriptions. RESULTS On the index dates 4,119 (60.5%) of 6,812 inpatients were receiving antibiotics. The random sample of 1,200 case patients was receiving 2,527 antibiotics (average: 2.1 per patient); 540 (21.4%) were prophylactic and 1,987 (78.6%) were therapeutic, of which 372 (18.7%) were pathogen-directed at start. Of the 1,615 empirical starts, 382 (23.7%) were subsequently pathogen-directed and 1,231 (76.2%) remained empirical. Use was primarily for respiratory (27.6% of prescriptions) followed by gastrointestinal (13.1%) infections. Fluoroquinolones, vancomycin, and antipseudomonal penicillins together accounted for 47.1% of therapy-days. CONCLUSIONS Use of broad-spectrum empirical therapy was prevalent in 6 US acute care facilities and in most instances was not subsequently pathogen directed. Fluoroquinolones, vancomycin, and antipseudomonal penicillins were the most frequently used antibiotics, particularly for respiratory indications. Infect. Control Hosp. Epidemiol. 2015;37(1):70-79.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26456803      PMCID: PMC7011437          DOI: 10.1017/ice.2015.226

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  38 in total

1.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.

Authors:  Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton
Journal:  Clin Infect Dis       Date:  2006-12-13       Impact factor: 9.079

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

3.  Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy.

Authors:  Ronald E Polk; Christina Fox; Anne Mahoney; Jim Letcavage; Conan MacDougall
Journal:  Clin Infect Dis       Date:  2007-01-22       Impact factor: 9.079

4.  Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections.

Authors:  Philipp Schuetz; Matthias Briel; Beat Mueller
Journal:  JAMA       Date:  2013-02-20       Impact factor: 56.272

5.  The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006.

Authors:  Faranak Ansari; Mats Erntell; Herman Goossens; Peter Davey
Journal:  Clin Infect Dis       Date:  2009-11-15       Impact factor: 9.079

Review 6.  Interventions to improve antibiotic prescribing practices for hospital inpatients.

Authors:  Peter Davey; Erwin Brown; Esmita Charani; Lynda Fenelon; Ian M Gould; Alison Holmes; Craig R Ramsay; Philip J Wiffen; Mark Wilcox
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30

7.  Variability in rates of use of antibacterials among 130 US hospitals and risk-adjustment models for interhospital comparison.

Authors:  Conan MacDougall; Ronald E Polk
Journal:  Infect Control Hosp Epidemiol       Date:  2008-03       Impact factor: 3.254

8.  Multistate point-prevalence survey of health care-associated infections.

Authors:  Shelley S Magill; Jonathan R Edwards; Wendy Bamberg; Zintars G Beldavs; Ghinwa Dumyati; Marion A Kainer; Ruth Lynfield; Meghan Maloney; Laura McAllister-Hollod; Joelle Nadle; Susan M Ray; Deborah L Thompson; Lucy E Wilson; Scott K Fridkin
Journal:  N Engl J Med       Date:  2014-03-27       Impact factor: 91.245

9.  Empirical use of antibiotics and adjustment of empirical antibiotic therapies in a university hospital: a prospective observational study.

Authors:  Julian Mettler; Mathew Simcock; Pedram Sendi; Andreas F Widmer; Roland Bingisser; Manuel Battegay; Ursula Fluckiger; Stefano Bassetti
Journal:  BMC Infect Dis       Date:  2007-03-26       Impact factor: 3.090

10.  Vital signs: improving antibiotic use among hospitalized patients.

Authors:  Scott Fridkin; James Baggs; Ryan Fagan; Shelley Magill; Lori A Pollack; Paul Malpiedi; Rachel Slayton; Karim Khader; Michael A Rubin; Makoto Jones; Matthew H Samore; Ghinwa Dumyati; Elizabeth Dodds-Ashley; James Meek; Kimberly Yousey-Hindes; John Jernigan; Nadine Shehab; Rosa Herrera; Clifford L McDonald; Amy Schneider; Arjun Srinivasan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-03-07       Impact factor: 17.586

View more
  15 in total

1.  Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats.

Authors:  Nathaniel J Rhodes; Walter C Prozialeck; Thomas P Lodise; Natarajan Venkatesan; J Nicholas O'Donnell; Gwendolyn Pais; Cameron Cluff; Peter C Lamar; Michael N Neely; Anil Gulati; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

2.  Vancomycin Area Under the Curve and Acute Kidney Injury: A Meta-analysis.

Authors:  Doaa M Aljefri; Sean N Avedissian; Nathaniel J Rhodes; Michael J Postelnick; Kevin Nguyen; Marc H Scheetz
Journal:  Clin Infect Dis       Date:  2019-11-13       Impact factor: 9.079

3.  24-Hour Pharmacokinetic Relationships for Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury.

Authors:  J Nicholas O'Donnell; Nathaniel J Rhodes; Thomas P Lodise; Walter C Prozialeck; Cristina M Miglis; Medha D Joshi; Natarajan Venkatesan; Gwendolyn Pais; Cameron Cluff; Peter C Lamar; Seema Briyal; John Z Day; Anil Gulati; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

4.  Investigating the Extremes of Antibiotic Use with an Epidemiologic Framework.

Authors:  Marc H Scheetz; Page E Crew; Cristina Miglis; Elise M Gilbert; Sarah H Sutton; J Nick O'Donnell; Michael Postelnick; Teresa Zembower; Nathaniel J Rhodes
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

5.  Eight unexpected cases of vancomycin associated acute kidney injury with contemporary dosing.

Authors:  J Nicholas O'Donnell; Cybele Ghossein; Nathaniel J Rhodes; Jessica Peng; Tina Lertharakul; C Kim Pham; Marc H Scheetz
Journal:  J Infect Chemother       Date:  2017-01-18       Impact factor: 2.211

6.  Comparative Performance of Urinary Biomarkers for Vancomycin-Induced Kidney Injury According to Timeline of Injury.

Authors:  Gwendolyn M Pais; Sean N Avedissian; J Nicholas O'Donnell; Nathaniel J Rhodes; Thomas P Lodise; Walter C Prozialeck; Peter C Lamar; Cameron Cluff; Anil Gulati; Julie C Fitzgerald; Kevin J Downes; Athena F Zuppa; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

7.  Evaluation of Fetal and Maternal Vancomycin-Induced Kidney Injury during Pregnancy in a Rat Model.

Authors:  Medha D Joshi; Gwendolyn M Pais; Jack Chang; Khrystyna Hlukhenka; Sean N Avedissian; Anil Gulati; Walter C Prozialeck; Peter C Lamar; Zhong Zhang; Marc H Scheetz; Brooke Griffin
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

8.  Trends in and Predictors of Carbapenem Consumption across North American Hospitals: Results from a Multicenter Survey by the MAD-ID Research Network.

Authors:  Nathaniel J Rhodes; Jamie L Wagner; Susan L Davis; John A Bosso; Debra A Goff; Michael J Rybak; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

9.  Twenty-four hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury in a rat model.

Authors:  Sean N Avedissian; Gwendolyn M Pais; J Nicholas O'Donnell; Thomas P Lodise; Jiajun Liu; Walter C Prozialeck; Medha D Joshi; Peter C Lamar; Leighton Becher; Anil Gulati; William Hope; Marc H Scheetz
Journal:  J Antimicrob Chemother       Date:  2019-08-01       Impact factor: 5.790

10.  Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival.

Authors:  Nathaniel J Rhodes; Joseph L Kuti; David P Nicolau; Scott Van Wart; Anthony M Nicasio; Jiajun Liu; Benjamin J Lee; Michael N Neely; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.